MiNK Therapeutics (INKT) EBT (2020 - 2026)
MiNK Therapeutics (INKT) posted EBT of -$2.8 million for Q1 2026, down 14.03% sequentially from -$2.4 million in Q4 2025, and down 6.24% YoY from -$3.0 million in Q1 2025.
MiNK Therapeutics (INKT) EBT (2020 - 2026) Analysis & Trends
MiNK Therapeutics has reported EBT for 7 years, with the latest figure at -$2.8 million in Q1 2026.
- Quarterly EBT fell 6.24% year-over-year to -$2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$20.0 million (down 47.58% YoY) and the FY2025 annual result came in at -$44.1 million, down 254.97% from the prior year.
- EBT fell to -$2.8 million in Q1 2026 per INKT's latest filing, from -$2.4 million in the prior quarter.
- Over five years, EBT peaked at -$2.4 million in Q4 2025 and troughed at -$13.1 million in Q1 2022.
- A 5-year average of -$6.8 million and a median of -$5.5 million in 2023 frame the typical range for EBT.
- The sharpest annual moves came in 2022 and 2024: EBT plunged 250.01% in 2022, then surged 61.69% in 2024.
- Over 5 years, EBT stood at -$7.9 million in 2022, then soared by 30.98% to -$5.5 million in 2023, then surged by 53.97% to -$2.5 million in 2024, then grew by 2.39% to -$2.4 million in 2025, then retreated by 14.03% to -$2.8 million in 2026.
- According to Business Quant data, EBT over the past three periods registered -$2.8 million, -$2.4 million, and -$9.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | MiNK Therapeutics | 57.77 Mn | 57.77 Mn | - | -3.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.47 Mn |
| Mar 31, 2026 | -2.79 Mn |
| Dec 31, 2025 | -2.45 Mn |
| Sep 30, 2025 | -9.32 Mn |
| Jun 30, 2025 | -5.41 Mn |
| Mar 31, 2025 | -2.63 Mn |
| Dec 31, 2024 | -2.51 Mn |
| Sep 30, 2024 | -3.29 Mn |
| Jun 30, 2024 | -5.11 Mn |
| Mar 31, 2024 | -3.79 Mn |
| Dec 31, 2023 | -5.45 Mn |
| Sep 30, 2023 | -7.53 Mn |
| Jun 30, 2023 | -10.81 Mn |
| Mar 31, 2023 | -9.90 Mn |
| Dec 31, 2022 | -7.90 Mn |
| Sep 30, 2022 | -12.65 Mn |
| Jun 30, 2022 | -10.96 Mn |
| Mar 31, 2022 | -13.13 Mn |
| Dec 31, 2021 | -7.17 Mn |
| Sep 30, 2021 | -21.45 Mn |